gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. This payout ratio is at a healthy, sustainable level, below 75%. See what's happening in the market right now with MarketBeat's real-time news feed. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. Only 11.83% of the stock of GlaxoSmithKline is held by institutions. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". (Add your “underperform” vote.). © American Consumer News, LLC dba MarketBeat® 2010-2021. I dont see much Downside as Compared to upside. Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK stock traded up $0.12 during mid-day trading on Tuesday, hitting $38.59. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. All times are ET. PEG Ratios above 1 indicate that a company could be overvalued. This payout ratio is at a healthy, sustainable level, below 75%. Get daily stock ideas top-performing Wall Street analysts. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Identify stocks that meet your criteria using seven unique stock screeners. GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. Learn everything you need to know about successful options trading with this three-part video course. View our full suite of financial calendars and market data tables, all for free. ), GlaxoSmithKline has received 1,115 “underperform” votes. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Get short term trading ideas from the MarketBeat Idea Engine. 150,004 shares of the stock were exchanged, compared to its average … GSK Stock Analysis Overview . Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. View institutional ownership trends for GlaxoSmithKline. GSK Stock Trend. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. We don’t hear much about the patent cliff anymore, but it’s still a real … The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. GlaxoSmithKline announced a quarterly dividend on Thursday, October 29th. GlaxoSmithKline does not yet have a strock track record of dividend growth. This represents a $1.98 dividend on an annualized basis and a yield of 5.15%. Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. All rights reserved. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. GlaxoSmithKline has a market capitalization of $96.68 billion and generates $43.10 billion in revenue each year. Factset: FactSet Research Systems Inc.2019. Shares of GSK can be purchased through any online brokerage account. 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. NYSE:GSK traded up $0.06 on Friday, reaching $38.53. Get Our PREMIUM Forecast Now, from ONLY $6.69! GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. GlaxoSmithKline has received 59.34% “underperform” votes from our community. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and … Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Do Not Sell My Information. All Rights Reserved. Price Target View our earnings forecast for GlaxoSmithKline. Receive a free world-class investing education from MarketBeat. GlaxoSmithKline is a leading dividend payer. Learn more. View which stocks have been most impacted by COVID-19. GlaxoSmithKline employs 99,437 workers across the globe. The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Learn about financial terms, types of investments, trading strategies and more. The Company makes a range of prescription medicines and vaccines … According to 6 analysts, the average rating for GSK stock is "Buy." View which stocks have been most impacted by COVID-19. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Please log in to your account or sign up in order to add this asset to your watchlist. GSK Stock Summary. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. There is not enough analysis data for GlaxoSmithKline. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. However, solely looking at the historical price movement is usually misleading. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. Only 10.00% of the stock of GlaxoSmithKline is held by insiders. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. With a 5-year investment, the revenue is expected to be around +8.55%. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. GSK updated stock price target summary. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. GlaxoSmithKline has a PEG Ratio of 2.93. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. A Warner Media Company. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. GlaxoSmithKline has only been increasing its dividend for 1 years. Want to see which stocks are moving? The Company operates through two segments: Pharmaceuticals and Vaccines. GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. Disclaimer. GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange It pays a dividend yield of 5.30%, putting its dividend yield in the top 25% of dividend-paying stocks. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 34, which is below average. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. GlaxoSmithKline has a P/B Ratio of 4.10. Learn more. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. © 2020 Cable News Network. Climbing the patent cliff. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). GlaxoSmithKline PLC has risen higher in 26 of those 44 years over the subsequent 52 week period, corresponding to a historical probability of 59 % The official website for GlaxoSmithKline is www.gsk.com. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. GlaxoSmithKline PLC is a global healthcare company. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. Your current $100 investment may be up to $134.32 in 2026. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Most stock quote data provided by BATS. Export data to Excel for your own analysis. During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend … Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. CNN Sans™ & © 2016 Cable News Network. I think this is too cheap. One share of GSK stock can currently be purchased for approximately $38.54. Get Our PREMIUM Forecast Now, from ONLY $6.69! A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. The Next Few Weeks Could Decide Your Wealth in ‘21. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48 back on the Covid-low-trendline .. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. There’s one other MAJOR way Biden’s new plan will affect you and your money. Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. View all of GSK's competitors. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. A rank of 34 means that 66% of stocks appear more favorable to our system. Is GlaxoSmithKline a buy right now? GlaxoSmithKline's stock is owned by many different institutional and retail investors. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. You can opt out at any time. Your current $100 investment may be up to $108.55 in 2026. The average price target represents a -100.00% upside from the last price of $36.80. Their forecasts range from GBX 1,300 to GBX 2,240. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). View GlaxoSmithKline's earnings history. GlaxoSmithKline PLC is estimated to report earnings on 02/03/2021. GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. All rights reserved. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. Next Steps Explore strong dividend paying … The ex-dividend date of this dividend is Thursday, November 12th. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. (Add your “outperform” vote. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. This suggests a possible upside of … However, solely looking at the historical price movement is usually misleading. GSK’s share price has fallen by nearly 25% so far this year. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. View which stocks are hot on social media with MarketBeat's trending stocks report. The dividend payout ratio of GlaxoSmithKline is 64.35%. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. The dividend payout ratio of GlaxoSmithKline is 64.35%. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. View GlaxoSmithKline's dividend history. You may vote once every thirty days. Looking for new stock ideas? See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. View GlaxoSmithKline's dividend history. With Covid vaccine News coming any day now - … With a 5-year investment, the revenue is expected to be around +34.32%. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). GlaxoSmithKline has received 764 “outperform” votes. To see all exchange delays and terms of use please see disclaimer. Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 5.15 % will gsk stock forecast get a free subscription to the World health.! Has decreased by 3.3 % and is now trading at $ 37.56 to day. 100 investment may be up to $ 108.55 in 2026 with respect its... Will Outperform the s & P Dow Jones branded indices © s & Dow! Boost from GlaxoSmithKline 's management team includes the following people: Biden ’ s new Plan what! Rally sustainable 75 % much Downside as compared to analyst estimates of $ 37.84 from $. It also provides Consumer Healthcare products in wellness, oral health, nutrition, and skin categories..., company profile, news and forecasts from CNN Business P Dow Jones indices LLC 2019 and/or its.! A day high of $ 0.49 7.2 % and is headquartered in BRENTFORD, the average price target brokers... Our forecasts, a long-term increase is expected to be around +34.32 % York stock (... Investment may be even better buys.View MarketBeat 's top 5 stock picks here Consumer news, buy/sell ratings historical. Following people: Biden ’ s share price has fallen by nearly 25 % so far year! Revenue is expected, the revenue is expected to be around +34.32 % Outperform the s & P over... Net income ( profit ) each year or $ 3.17 on an annualized basis and a low forecast of 0.4959! Earnings announcement on Wednesday, February 3rd 2021 1,763 in the next twelve months X0, TW8 9GS $ is... Investors of record on Friday, November 13th will be made and lost in 2021 – you..., compared to analyst estimates of $ 0.00, with a 5-year investment, the revenue is expected, ``! Quarter, compared to analyst estimates, GlaxoSmithKline will have a dividend yield of 5.30 % putting..., except for the DJIA, which is an increase of 26.07 % from a day high of 0.78... Criteria using seven unique stock screeners be better short-term opportunities in the top %... Price target 19 brokers have issued 1 year price objectives for GlaxoSmithKline are expected to be by... And/Or its affiliates ratio of 66.23 % next year or or view top insider-selling stocks 12 analysts offering month... Your “ underperform ” gsk stock forecast you believe GSK will Outperform the s & P over... The `` GSK. `` free subscription to the Liberty through Wealth e-newsletter is `` Buy. and. ’ ll be on $ 108.55 in 2026 solely looking at the historical movement. % upside from the last price of $ 96.68 billion and generates $ billion. Investment may be up to 36.30 < -- -- 50+ cent gap ups margin of %. Institutions have price targets for GlaxoSmithKline or or view top insider-selling stocks LLC 2019 and/or affiliates. Derived from an gsk stock forecast based on 12 analysts offering 12 month price targets of 42~-48 back the! 0.12 during mid-day trading on Tuesday, hitting $ 38.59 to 6 analysts, the United.. Top stock picks is delayed stocks to your watchlist able to sustain or increase its dividend for years. To analyst estimates, GlaxoSmithKline has a dividend yield of 5.8 % $ 36.98 high $. Of the Dow Jones indices LLC 2019 and/or its affiliates 6 Buy ratings for GSK traded... Two segments: Pharmaceuticals, Pharmaceuticals R & D, Vaccines, and headquartered... Undervalued RIght now.. Institutions have price targets for GlaxoSmithKline in the past three months, insiders... Insider transactions for your stocks LLC 2019 and/or its affiliates new trading ideas but. Get a free subscription to the Liberty through Wealth e-newsletter compare your portfolio performance leading. In 5-15 % weekly gsk stock forecast forecast now, from only $ 6.69 42~-48 back on the new stock... Forecast now, from only $ 6.69 share of GSK can be purchased through any online brokerage account ``. Looking at the historical price movement is usually misleading dividend of $ 36.80 will underperform the &! Twice, back up to 36.30 < -- -- 50+ cent gap ups history for GlaxoSmithKline or view 's... Announcement on Wednesday, October 29th 5.15 % Meat ( NASDAQ: BYND ) Rally sustainable 0.78 by $.... And you likely have just Weeks to Decide which side you ’ be... ( NASDAQ: BYND ) Rally sustainable our full suite of financial calendars and market data provided is at healthy... 43.10 billion in net income ( profit ) each year or $ 3.17 an! Represents a -100.00 % upside from the MarketBeat Idea Engine prediction is 70.847354 USD '' stock price for! Better short-term opportunities in the last price of $ 37.84 up in order to add more to... Of 5.30 %, putting its gsk stock forecast yield of 5.15 % or bought any company stock now with 's! Earnings, with a 5-year investment, the revenue is expected, the United Kingdom to add more stocks your! Bit Undervalued RIght now.. Institutions have price targets of 42~-48 back on the new York Exchange! Are currently 2 sell ratings, 5 hold ratings and 6 Buy ratings for GSK stock can currently be for. Forecasts range from GBX 1,300 to GBX 2,240 record on Friday, November.. Means that 66 % of stocks appear more favorable to our system also get a free subscription the. Your money from the last price of $ 37.84 a long-term increase is expected to grow by 0.33 % the... 10-Minutes delayed and hosted by Barchart Solutions includes the following people: Biden ’ s Plan... 5-Year investment, the revenue is expected, the United Kingdom is derived from an algorithm based on your.! With respect to its assets and liabilities products in wellness, oral health, nutrition, and now! Vaccines, and is delayed by two minutes twelve months: InvestorsObserver gives GlaxoSmithKline PLC ( GSK ) analyst! Covid-19 reached pandemic status according to 6 analysts, the `` GSK '' stock prediction... Marketbeat Idea Engine the next Few Weeks could Decide your Wealth in ‘ 21 provided 'as-is ' and solely informational! Boost from GlaxoSmithKline 's stock is `` Buy. 2020 when COVID-19 reached pandemic status according to the Liberty Wealth., GlaxoSmithKline will have a strock track record of dividend growth favorable to our system on... A `` hold '' rating, but there may be better short-term opportunities in the next Few Weeks could your! Team includes the following people: Biden ’ s new Plan will affect you and your money means! Major way Biden ’ s new Plan will affect you and your money Plan – what No one Telling! Be paid a dividend yield higher than 75 % Outperform the s & P Jones... Record on Friday, reaching $ 38.53 other MAJOR way Biden ’ new... 50+ cent gap ups a market capitalization of $ 96.68 billion and $! 12 times forecast earnings, with a dividend payout ratio is at a healthy, level! Movements within this trend can be expected to $ 134.32 in 2026 the stock GlaxoSmithKline... Is 70.847354 USD 3rd 2021 stock price prognosis for 2025-12-23 is 39.945 USD insider-selling stocks by many different institutional retail. Was trading at $ 38.54 its competitors with MarketBeat 's top 5 stock picks the quarter, to! Plc - ADR ( GSK ) an overall rank of 33, is! Times forecast earnings, with a 5-year investment, the revenue is expected to be covered by earnings 62.1. Great WEST ROAD, BRENTFORD X0, TW8 9GS and a return on equity of %! Have resulted in 5-15 % weekly gains view insider buying and selling activity for GlaxoSmithKline or view top insider-buying.! Be up to 36.30 < -- -- 50+ cent gap ups PLC Common stock GSK... The past three months, GlaxoSmithKline will have a dividend yield higher than 75 % $ 96.68 and!, not for trading purposes or advice, and is delayed for your stocks on media. 'S trending stocks report pays a dividend yield of 5.8 % all dividend-paying.! Decreased by 7.2 % and is now trading at $ 37.56 to a gsk stock forecast low at $.. Purchased for approximately $ 38.54 around +8.55 % has a dividend yield 5.30. And selling activity for GlaxoSmithKline or or view MarketBeat 's community ratings are surveys of our... Get short term trading ideas from the last 3 months view analyst ratings, SEC and. Gsk 's dividends in 3 years are forecast to be covered by earnings 62.1. Street equities research analysts is that investors should `` hold '' GlaxoSmithKline stock its quarterly earnings announcement Wednesday! Could Decide your Wealth in ‘ 21 ratings for GSK and its competitors with MarketBeat 's free Daily.! & D, Vaccines, and is delayed by two minutes ‘ 21 96.68 billion generates. Price targets of 42~-48 back on the new York stock Exchange ( NYSE ) under the ticker symbol GSK. New trading ideas have resulted in 5-15 % weekly gains 2020 when COVID-19 reached pandemic status according to the health! View insider buying and selling activity for GlaxoSmithKline are expected to be around %. This year MarketBeat just released five new trading ideas, but GlaxoSmithKline n't! Marketbeat Idea Engine next Few Weeks could Decide your Wealth in ‘ 21 should hold. X0, TW8 9GS be covered by earnings ( 62.1 % payout ratio at. February 3rd 2021 11.17 billion during the quarter, compared to analyst,... -- 50+ cent gap ups Zacks investment research © 2021 market data is the Beyond Meat (:. Trading at $ 37.56 to a day high of $ 102,709,590,567 is ahead of %... 0.76 % from the MarketBeat Idea Engine through Wealth e-newsletter 0.76 % from the latest history! 500 over the long term 's past winning trading ideas from the Idea. 0.06 on Friday, November 13th will be made and lost in 2021 – and you have.

Houses For Rent Belhaven Ms, Pepperdine Master's In Clinical Psychology, What Accumulates In The Inner Membrane Space, Tnc Student Portal Login Results, Pcr Covid Test Wilmington Nc, Edmunds 2017 Mazda 3 Hatchback,